← Back to news
Y

Yahoo Finance

I'm Calling It: GE Vernova (GEV) Is a Buy Before This Catalyst Drops

Y

Forget SpaceX: See This Overlooked AI Stock in Donald Trump’s Portfolio

Y

Prediction: Will Dell Hit $500 This Year?

Y

Prediction: Netflix Will Reach $100 on This Date

Y

Super Micro Jumped More Than 10%. Is the AI Server Maker Finally Turning a Corner?

Y

New research finds a 'collateral gap' in Bitcoin lending

Y

Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026?

Y

Is AI a Threat to S&P Global? The Answer May Surprise Investors.

Y

Google Losing Top AI Executive Is ‘The Most Significant AI Talent Move of the Year.’ Is It Time to Sell Alphabet Stock?

Y

How Much Can a 62-Year-Old Couple With $2.3 Million in Their 401(k) Save With Roth Conversions?

Y

Costco members voice surprising inventory complaint

Y

Lilly's 7 Acquisitions in 3 Months: Which Will Be the Biggest Game-Changer for the Pharma Giant?

Y

Jim Cramer Says SpaceX 'Could Not Maintain Its Meme Status' As Rally Stalls: 'Too Many Sellers'

Y

Mark Cuban Says the Stock Market Makes Guys Like Elon Musk ‘Insanely Rich’ — But Eliminating Billionaires Would Trigger the ‘Worst Depression’ Ever Seen

Y

Hyperliquid loses Anthropic, OpenAI markets

Y

Arizona Gold & Silver CEO discusses expanded drilling and growth plans - ICYMI

Y

Week’s Best: Hardship Retirement Withdrawals on the Rise

Y

Expert Predicts Drones Are the ‘Unlikely Catalyst’ for Battery Breakthroughs. Time to Buy AeroVironment, Ondas, and Red Cat?

Y

SpaceX IPO Could Ignite Fresh Market Momentum, Says Evercore

Y

What Happened to 2024's Top Cryptocurrencies? Here's Who Graduated and Who Got Held Back.

Y

3 Questions to Ask Your Financial Advisor Before You Retire in 2027

Y

This Space Stock Will Beat SpaceX to the Nasdaq-100 — And It’s the One to Buy

Y

Energy Expert: Electric Vehicles Are the ‘Keystone Species’ of the Next Megatrend. Will Tesla’s Stock See Massive Gains?

Y

First Phosphate gains G7 critical minerals backing – ICYMI

Y

This Century-Old Financial Giant's Reverse Stock Split Leaves Investors Puzzled

Y

Our Highest Conviction Call on Disney Points to $110 on Earnings Growth

Y

DOL Investment-Selection Proposed Regulations: What Advisors and Clients Are Saying

Y

3 Retail Winners Using Cash Flow to Stay Ahead

Y

You Didn’t Sell a Thing — but a $30,000 Fund Payout Just Raised Your 2028 Medicare Bill

Y

Sandisk Stock Is Up More Than 5,900% Since It Spun Off From Western Digital. Is It Too Late to Buy?

Y

Bank ETF Showdown: Invesco Crushes iShares

Y

What Is the Vanguard Energy ETF (VDE) and Who Should Buy It?

Y

Why Jim Cramer says Ford's real story isn't trucks or EVs

Y

Wall Street Technician Declares Financials, Industrials, and Biotech Poised for Breakouts. 3 ETFs Could Soar.

Y

The Department of Education just quadrupled a key discount for student loan borrowers — but the clock is ticking

Y

The Nuclear Regulatory Commission Formally Accepted Nano Nuclear's Construction Permit Application. Here's What That Means for Investors.

Y

Sandisk AI Memory Boom Is Far From Over

Y

Rivian Is Cutting Staff Again. What That Means for RIVN Stock.

Y

From ‘Hold’ to ‘Buy’: Here Is Why Truist Just Changed Its Mind on DDOG Stock

Y

Dear Investors: Don’t Act Your Age, Act Your Risk Tolerance

Y

Robinhood backs push to scrap a market rule most traders don't know exists

Y

She’s 81, Her House Is Paid Off, and Property Taxes Keep Rising. Can She Afford to Stay?

Y

A Surprising Retirement Withdrawal Strategy Could Leave You With More Money Later

Y

Why Bernstein Just Raised Its Price Target on Arm Stock by Nearly 70%

Y

Jim Cramer Says Banks Like JPMorgan (JPM) “Are Still Inexpensive”

Y

Jim Cramer Calls for Bank Mergers and Praises Banco Santander (SAN)

Y

Jim Cramer Highlights Goldman Sachs (GS) as Investment Banking Activity Explodes

Y

Jim Cramer Says Stryker (SYK) and Its Orthopedic Peers Are Facing a Real Tough Run

Y

Jim Cramer on Vistra (VST): “It’s Just Fallen Enough”

Y

Jim Cramer Says Clover Health (CLOV) Was a Good Speculative Pick But Still Prefers UnitedHealth and CVS

Y